-
Hymon® Pan-Cancer Screening Test Kit
The Pan-Cancer Screening Test uses gene methylation and other HymonBio’s patented technologies on the PCR platform to detect up to 28 types of cancer in blood samples.
-
Hymon® Respiratory Triplex Panel Test Kit
Hymon® Respiratory Triplex Panel Test Kit applies innovative “one-step method” to solve the cumbersome problem of nucleic acid extraction for SARS-CoV-2, influenza A and influenza B viruses; The nucleic acid is automatically released in 3 minutes, with sample-to-results as short as 35 minutes. Based on MoLock (nano-antibody molecular lock technology) and dual internal standard design, it achieves high sensitivity, high specificity, and full-process monitoring. A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses by multiplex testing.
-
HAEMOCERT™ Colorectal Cancer Screening Test
HAEMOCERT™ Colorectal Cancer Screening Test has passed CE certification and is used for early colorectal cancer screening. Tests for 3 gene methylation and 1 gene mutation. -
Hymon® SARS-CoV-2 Test Kit
Hymon® SARS-CoV-2 Test Kit provides in vitro detection of the coronavirus SARS-CoV-2 in nasopharyngeal/oropharyngeal swab and other respiratory samples. The virus infects human and causes COVID-19.
This test kit has received US FDA Emergency Use Authorization and European Union CE Certificate.
-
Hymon® MULTONE™ Respiratory Panel Test Kit
Hymon® provides a flexible, quantitative PCR respiratory detection solution for quick and sensitive clinical testing, and provide accurate detection results for some of the most common respiratory diseases. Hymon® MULTONE™ Respiratory Panel Test Kit adopts multiple qPCR technology and provides a combination panel for simultaneously detecting 12 different pathogens.
-
Hymon® MULTONE™ Urogenital Panel Test Kit
Hymon® provides a flexible, quantitative PCR detection solution for quick and sensitive clinical testing, and provide accurate detection results for some of the most common urogenital diseases. Hymon® MULTONETM Urogenital Panel adopts multiple qPCR technology and provides a combination panel for simultaneously detecting 18 different pathogens.
-
Hymon® Urine Bladder Cancer Screening
HymonBio Bladder Cancer Gene Methylation Detection Kit is used to detect specific gene methylation of exfoliated cells in urine. This kit uses innovative multi-gene detection technology, combined with original NPC Nucleic Acid Extraction technology to better protect the integrity of cellular DNA and greatly improve sensitivity and specificity. The sensitivity was 92%, and the specificity was 94%. The kit uses non-invasive urine samples, making testing convenient and improves compliance, and providing a non-invasive technical means for monitoring recurrence after clinical treatment.
-
Hymon® Blood Gastric Cancer Screening
HymonBio Gastric Cancer Gene Methylation Detection Kit uses 2 specific gene methylation of circulating tumor DNA (cfDNA) in blood samples. This kit uses innovative multi-gene detection technology, combined with original Magnetic Bead Extraction technology improving efficiency of low-concentration small fragment cell-free nucleic acid, and hence has higher sensitivity and specificity; clinical studies have shown a sensitivity of 89% and specificity of 91%. The kit uses non-invasive blood samples, making testing convenient and improves compliance, and providing a non-invasive technical means for monitoring recurrence after clinical treatment.
-
Hymon® Clopidogrel-Resistance Gene Polymorphism Detection Kit
This kit uses RT-PCR for in vitro detection of CYP2C9*2, *3, and *17 polymorphism associated with clopidogrel resistance in peripheral blood, identify gene polymorphism between different patients and provide the basis for individualized clopidogrel medication.
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
-
Hymon® Neural Tube Defect Gene Polymorphism Detection Kit
This kit uses RT-PCR for detecting MTHFR 677C>T, 1298(A>C), and MTRR66A>G polymorphism in peripheral blood, identify gene polymorphism between different patients and provide the basis for individualized nitroglycerin medication.
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
-
Hymon® Metabolic Enzyme Gene Polymorphism Detection Kit
This kit uses RT-PCR for in vitro detection of APOE 338T>C, 526C>T, SLCO1B1 388A>G, and 521T>C polymorphism in peripheral blood, identify gene polymorphism between different patients and provide the basis for individualized nitroglycerin medication.
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
-
Hymon® ALDH2 Gene Polymorphism Detection Kit
This kit uses RT-PCR for in vitro detection of ALDH2*2 (1510G>A) gene polymorphism in peripheral blood, identify gene polymorphism between different patients and provide the basis for individualized nitroglycerin medication.
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
